- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.03. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 12.03.2026 | 677 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 12.03.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 12.03.2026.ISIN NameCA53044R8839 LIB.DEF.HO.... ► Artikel lesen | |
| 05.03. | XFRA K1Z0: AUSSETZUNG/SUSPENSION | 287 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCHORDATE MEDICAL... ► Artikel lesen | |
| 18.02. | Chordate Medical Holding AB: Chordate Medical's application for delisting has been approved | 256 | GlobeNewswire (Europe) | Chordate Medical Holding AB (publ) ("Chordate" or "the Company") application for delisting of the Company's ordinary shares with ISIN SE0022726139 and preference shares with ISIN SE0023848619 has now... ► Artikel lesen | |
| 18.02. | Chordate Medical Holding AB: Chordate Medical applies for delisting | 587 | GlobeNewswire (Europe) | Following the general meeting of Chordate Medical Holding AB (publ) ("Chordate" or "the Company") resolution to delist the Company's shares and to liquidate the Company, the liquidator has decided to... ► Artikel lesen | |
| CHORDATE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 16.01. | Chordate Medical Holding AB: Chordate Medical announces updated timetable for delisting | 254 | GlobeNewswire (Europe) | The general meeting of Chordate Medical Holding AB (publ) ("Chordate" or "the Company") resolved at an extraordinary general meeting on 8 December 2025, among other things, to delist the Company's shares.... ► Artikel lesen | |
| 16.12.25 | Chordate Medical Holding AB: Chordate Medical terminates the liquidity guarantee for the common share | 283 | GlobeNewswire (Europe) | Chordate Medical hereby announces that the company has terminated the agreement with Lago Kapital regarding the assignment as liquidity provider for the common share CMH.
The purpose of the liquidity... ► Artikel lesen | |
| 08.12.25 | Chordate Medical Holding AB: Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ) | 190 | GlobeNewswire (Europe) | At the Extraordinary General Meeting of Chordate Medical Holding AB (publ), held on December 8, 2025, the following resolution was passed. All resolutions were adopted in accordance with the proposals... ► Artikel lesen | |
| 19.11.25 | Chordate Medical Holding AB (publ) receives observation status | 220 | GlobeNewswire | Yesterday, November 18, 2025, Chordate Medical Holding AB (publ) (the "Company") disclosed a notice convening an extraordinary general meeting of the Company's shareholders, with a proposal for voluntary... ► Artikel lesen | |
| 21.08.25 | Chordate Medical Holding AB: Chordate Medical Announces Cost Reduction and Focus on Company Sale | 305 | GlobeNewswire (Europe) | Chordate Medical Holding AB (Publ.) (the "Company") has adopted a cost reduction program that includes focusing activities on the continued ambition to sell the Company. Together with the recently completed... ► Artikel lesen | |
| 19.08.25 | Chordate Medical Holding AB: Chordate Medical reports preliminary conclusions from long-term study on chronic migraine: PM010 | 286 | GlobeNewswire (Europe) | Since this Post Market Surveillance study is open-label (uncontrolled), it is possible - and the sponsor's responsibility - to actively monitor study data during the ongoing trial. It is both scientifically... ► Artikel lesen | |
| 17.07.25 | Chordate Medical Holding AB: Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ) | 356 | GlobeNewswire (Europe) | At the Extraordinary General Meeting of Chordate Medical Holding AB (publ), held on 17 July 2025, the following resolution was passed. All resolutions were adopted in accordance with the proposals previously... ► Artikel lesen |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ICECURE MEDICAL | 6,355 | -0,70 % | IceCure Medical: IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance | Increase driven by FDA clearance, clinical guideline support, and increased physician demand. Significant rise in number of leads for ProSense® systems generated... ► Artikel lesen | |
| GENEDX | 56,42 | 0,00 % | GeneDx Names Mark Gardner as President | ||
| PROCEPT BIOROBOTICS | 20,910 | 0,00 % | PROCEPT BioRobotics shares slide after Leerink downgrade cites rising competitive risks | ||
| ALIGNMENT HEALTHCARE | 21,425 | +0,02 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 64,36 | -0,11 % | BrightSpring Health Services, Inc. - 8-K, Current Report | ||
| CLEARPOINT NEURO | 16,750 | -0,36 % | Clearpoint Neuro Aktie schießt nach oben: FDA ebnet Partner UniQure den Weg zur Zulassung | ||
| ADAPTHEALTH | 9,530 | 0,00 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
| BILLIONTOONE | 99,29 | -0,09 % | BillionToOne, Inc. - 8-K, Current Report | ||
| LIFESTANCE HEALTH GROUP | 8,605 | -0,06 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| PROGYNY | 26,330 | +0,08 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| HEARTFLOW | 32,820 | -0,06 % | Piper Sandler bestätigt Rating für Heartflow: Plaque-Umsätze sollen Wachstum antreiben | ||
| LIFEMD | 4,910 | 0,00 % | LifeMD, Inc.: LifeMD Appoints Umesh Sripad as Chief Technology Officer | NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Umesh Sripad as Chief Technology Officer... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 7,535 | -0,07 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance | ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| BETA BIONICS | 13,180 | -0,08 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 5,245 | -0,10 % | Needham raises Oncology Institute stock price target to $7 on growth outlook |
Das Unternehmen CHORDATE MEDICAL HOLDING AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,001 Euro.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHORDATE MEDICAL HOLDING AB finden Sie auf Wallstreet Online.